Industry NewsPediatric Cancer

Mevion to Open First Pediatric Proton Center in China

By News Release


A partnership between Mevion Medical Systems and Children’s Hospital of Fudan University in Shanghai and Shanghai Fosun Healthcare (Group) Co., Ltd. will lead to the first pediatric proton therapy center in China. As part of the agreement, the three parties will collaborate on the proton therapy center’s development, clinical services, training, and research activities.

The new proton therapy center will be located at StarKids Children’s Hospital Shanghai, on the New Hong Qiao campus of Children’s Hospital of Fudan University. Founded in 1952, the Children’s Hospital of Fudan University is one of the top children’s hospitals in China, leading in clinical services, teaching, and research.

“This joint collaboration represents a significant milestone for Mevion and pediatric patients in China. By providing the first pediatric hospital in China with direct access to proton therapy, together we embark on a new era of patient care that will provide our life-changing technology to children and their families”, said Tina Yu, chief executive officer of Mevion Medical Systems. “We are proud to continue to fulfill our mission to provide accessible proton therapy to every corner of the globe.”

According to GLOBALCON 2020, the estimated number of new pediatric cancer patients in China last year was 36,651. However, the lack of operating proton centers and specialized medical professionals has significantly limited Chinese pediatric patients’ access to proton therapy.